Background: Uveitis is a sight-threatening inflammation which may involve different anatomic parts inside the eye. Rheumatologists should be aware of the ocular clinical signs and of the frequency of uveitis because it may cause irreversible lesions to the eye that predominantly affect people in their most productive years, being one of the most common extra-articular manifestation in several rheumatic diseases. Objectives: We aimed to describe the presentation of the clinical features of ocular involvement in a population of patients affected with newly diagnosed Non Infectious Uveitis (NIU). Methods: 278 patients (mean age 42±18,18 years, range 4 -87) from three specialized centres, all affected with uveitides, were enrolled; 158 were female, 120 male, all caucasian but one asiatic. Complete ophtalmologic examination was carried out in all of them, malignancy or infections of any kind were preventively ruled out. In addition blood tests, serum antibodies level evaluation and HLA haplotype typization were performed. Moreover instrumental tests were performed when a relation with systemic diseases was suspected. Uveitides were then classified according to the Standardization of Uveitis Nomenclature Working Group Criteria. Results: 149 (53,6%) patients were affected with Anterior Uveitis (AU), 45 (16,2%) with Panuveitis, 16 (5,8%) with Intermediate Uveitis (IU) and 68 (24,5%) with Posterior Uveitis (PU). 110 (41,7%) patients were known to have a systemic disease at the moment of the uveitis onset. HLA-B27 positivity was found in 15,8% of patients, whereas HLA-B51 positivity was found in 21,9% of patients. Behçet's Disease (BD) was diagnosed in 39 (14%) patients: in particular AU was found in 9 out of 39 patients (23,1%), while PU in 16 out of 39 patients (41%). Ankylosing Spondylitis (AS) was recognized in 22 (7,9%) patients: AU was diagnosed in 16 out of 22 (72,7%) of them while 4 out of 22 (18,2%) where affected with Panuveitis. The cases of Psoriatic Arthritis (PsA) were 9 (3,2%); specifically, AU was recognized in 4 out of 9 (44,4%) of them while PU was found in 5 out of 9 (55,6%) of them. We also defined the most common form of uveitis in patients affected with either Juvenile Idiopathic Arthritis, or Systemic Lupus Erythematosus, or Sarcoidosis, or Vogt-Koyanagi-Harada disease or Inflammatory Bowel Diseases. The idiopathic form of uveitis, was diagnosed in 162 (58,3%) patients. Anti-nuclear antibodies (ANA) levels were assessed in 148 patients of whom 57 (38,5%) have been found ANA positive and 91 (61,5%) ANA negative. Notably 38 (66,7%) ANA positive patients were affected with AU.
Conclusions:
Our study provides a depiction of clinical features and epidemiology of ocular involvement in a huge population of patients presenting newly diagnosed NIU. Notably, in our population, idiopathic uveitis was the most commonly diagnosed form; it took shape of AU in 56,6% of cases. The majority of HLA-B27 positive uveitides were also AU (68,2%), while, among HLA-B51 uveitides, PU (39,3%) and AU (37,7%) were recognized as the most common presentations. Background: Ankylosing Spondylitis (AS) is a chronic rheumatic disease that affects mainly the axial skeleton and entheses. If left untreated, AS evolves with limited spine mobility and irreversible structural changes, with severe repercussions in patients' quality of life. Throughout the years many instruments have been used in order to evaluate AS impact in patients' lives, focusing predominantly on symptoms and functioning however, these instruments do not inform on the impact of the condition on quality of life (QoL). The ASQoL is a patient reported outcome measure, specifically developed to evaluate QoL in AS patients. It has been adapted to several languages worldwide, though a Portuguese version hadn't been developed yet. Objectives: Translation of the ASQoL questionnaire into Portuguese and ascertain its psychometric properties. Methods: Translation of the original UK English ASQoL into Portuguese was performed by bilingual panel and then assessed by a lay panel. Cognitive debriefing interviews were performed with AS patients to assess face and content validity. Finally, a sample of AS patients were included in a test-retest postal survey, administered on two different occasions, two weeks apart, to investigate the reliability and construct validity of the new Portuguese adaptation of the ASQoL. Nottingham Health Profile (NHP) was used as a comparator measure. Results: The Portuguese version of ASQoL proved to be relevant and easy to understand. Validation of the ASQoL included fifty-eight AS patients, with a mean age of 51 years (Range 25.0 -80.0), with 55.2% males. The Portuguese ASQoL had good internal consistency at Time 1 (α =0.93) and Time 2 (α =0.91). Test-retest reliability was excellent, with a strong positive correlation between scores at two time points (r=0.92, p<0.001). Correlation between ASQoL scores and NHP was moderately strong with Spearman's rank correlation coefficients between ASQoL and NHP section scores, including the distress scale embedded within, all p<0.001. These results suggest that patient's quality of life is influenced by many factors in addition to disease severity, including social skills and ability to adapt to physical limitations. The Portuguese version of ASQoL was able to discriminate between patients who differed on their perception of general health and presence of comorbidity, although there were no significant differences according to self-perception of disease severity.
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